MedTrace Logo

Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.

NCT06752122 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-11-20

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of RCS-21 in healthy volunteers. Participants will be asked to inhale a single dose of RCS-21 and their health status will be constantly monitored.

Conditions

  • Healthy Volunteers
  • Safety
  • Tolerability
  • Pharmacokinetics

Interventions

DRUG

Placebo (SAD)

Inhalation of a single dose.

DRUG

RCS-21 (SAD)

Inhalation of a single dose.

Sponsors & Collaborators

  • LungenClinic Grosshansdorf

    collaborator OTHER

  • RNATICS GmbH

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-18
Primary Completion
2026-06-30
Completion
2026-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06752122 on ClinicalTrials.gov